Onward Medical N.V.
ONWRF
$4.60
-$0.39-7.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 816.00K | 841.60K | 111.90K | 112.90K | -213.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 816.00K | 841.60K | 111.90K | 112.90K | -213.20K |
| Cost of Revenue | 3.85M | 3.97M | 3.60M | 3.63M | 3.64M |
| Gross Profit | -3.03M | -3.13M | -3.48M | -3.51M | -3.85M |
| SG&A Expenses | 4.44M | 4.58M | 5.16M | 5.20M | 3.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.39M | 9.69M | 10.20M | 10.29M | 8.77M |
| Operating Income | -8.58M | -8.85M | -10.09M | -10.18M | -8.98M |
| Income Before Tax | -9.16M | -9.45M | -9.99M | -10.08M | -9.06M |
| Income Tax Expenses | 148.20K | 152.80K | -171.10K | -172.60K | 33.40K |
| Earnings from Continuing Operations | -9.31M | -9.60M | -9.82M | -9.91M | -9.10M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.31M | -9.60M | -9.82M | -9.91M | -9.10M |
| EBIT | -8.58M | -8.85M | -10.09M | -10.18M | -8.98M |
| EBITDA | -8.49M | -8.71M | -9.86M | -9.94M | -8.92M |
| EPS Basic | -0.17 | -0.18 | -0.28 | -0.29 | -0.30 |
| Normalized Basic EPS | -0.10 | -0.11 | -0.18 | -0.18 | -0.19 |
| EPS Diluted | -0.17 | -0.18 | -0.29 | -0.29 | -0.30 |
| Normalized Diluted EPS | -0.10 | -0.11 | -0.18 | -0.18 | -0.19 |
| Average Basic Shares Outstanding | 54.63M | 54.63M | 34.63M | 34.63M | 30.24M |
| Average Diluted Shares Outstanding | 54.63M | 54.63M | 34.63M | 34.63M | 30.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |